Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of CRx-191 to Assess Activity in Plaque Psoriasis

This study has been completed.
Sponsor:
Collaborator:
Bioskin GmbH
Information provided by:
Zalicus
ClinicalTrials.gov Identifier:
NCT00557739
First received: November 12, 2007
Last updated: September 24, 2008
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2008
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)